BerteroL., MassaF., MetovicJ., ZanettiR., CastellanoI., RicardiU., PapottiM., and CassoniP. (2017). ‘Eighth Edition of the UICC Classification of Malignant Tumours: an overview of the changes in the pathological TNM classification criteria-What has changed and why?,’ Virchows Arch.472, 519–531.
2.
CarrollP.R., ParsonsJ.K., AndrioleG., BahnsonR.R., CastleE.P., CatalonaW.J., DahlD.M., DavisJ.W., EpsteinJ.I., EtzioniR.B., FarringtonT., HemstreetG.P.III, KawachiM.H., KimS., LangeP.H., LoughlinK.R., LowranceW., MaroniP., MohlerJ., MorganT.M., MosesK.A., NadlerR.B., PochM., ScalesC., ShaneyfeltT.M., SmaldoneM.C., SonnG., SprenkleP., VickersA.J., WakeR., SheadD.A., and Freedman-CassD.A. (2016). ‘NCCN Guidelines Insights: Prostate Cancer Early Detection, Version 2.2016,’ J. Natl. Compr. Canc. Netw.14, 509–519.
HermanekP., WittekindC., and AltendorfhofmannA. (1994). ‘Uicc Classification of pancreatic ductal adenocarcinoma,’ Int. J. Pancreatol.16, 230–232.
5.
IAEA (2000). International Atomic Energy Agency. Absorbed Dose Determination in External Beam Radiotherapy: An International Code of Practice for Dosimetry based on Standards of Absorbed Dose to Water. IAEA TRS-398 (International Atomic Energy Agency, Vienna).
6.
RossiS. (2015). ‘The National Centre for Oncological Hadrontherapy (CNAO): status and perspectives,’ Phys. Med.31, 333–351.